Calidi Biotherapeutics (CLDI) Shareholder's Equity (2021 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shareholder's Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,638,563.89 Bn | 1,638,563.89 Bn | - | 595,226.00 |
| 2 | Alterity Therapeutics | 767,934.24 Bn | 767,934.20 Bn | - | - |
| 3 | Legend Biotech | 2,937.00 Bn | 2,936.10 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,282.79 Bn | 2,282.72 Bn | - | - |
| 5 | Akari Therapeutics | 2,169.69 Bn | 2,169.69 Bn | - | 14.38 Mn |
| 6 | Vertex Pharmaceuticals | 110.41 Bn | 103.16 Bn | 2.59 Bn | 19.36 Bn |
| 7 | Regeneron Pharmaceuticals | 66.44 Bn | 57.69 Bn | 3.31 Bn | 31.42 Bn |
| 8 | Evaxion A | 65.44 Bn | 65.42 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.53 Bn | 36.52 Bn | 959.66 Mn | 1.08 Bn |
| 10 | Calidi Biotherapeutics | - | - | - | 3.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.76 Mn |
| Sep 30, 2025 | 7.20 Mn |
| Jun 30, 2025 | 2.08 Mn |
| Mar 31, 2025 | 7.30 Mn |
| Dec 31, 2024 | 1.97 Mn |
| Sep 30, 2024 | -9.80 Mn |
| Jun 30, 2024 | -11.75 Mn |
| Mar 31, 2024 | -14.57 Mn |
| Dec 31, 2023 | -8.24 Mn |
| Sep 30, 2023 | -1.09 Mn |
| Jun 30, 2023 | -63.71 Mn |
| Mar 31, 2023 | -55.10 Mn |
| Dec 31, 2022 | -50.44 Mn |
| Sep 30, 2022 | -43.93 Mn |
| Jun 30, 2022 | -39.64 Mn |
| Mar 31, 2022 | -37.62 Mn |
| Dec 31, 2021 | -31.61 Mn |